Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

Recruiting now

Conditions studied: Mesonephric-like Adenocarcinoma

In brief

To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.

Key facts

Study ID

NCT06377527

Run by

M.D. Anderson Cancer Center

People needed

2000

Starts

2024-07-10

Expected to finish

2037-12-28

Last updated by the study team

2026-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients over the age of 18.
• Patients with a diagnosis of gynecologic mesonephric-like adenocarcinoma (MLA), mesonephric adenocarcinoma (MA), mesonephric carcinosarcoma, or mesonephric-like carcinosarcomas.
• For patients who provide consent, they must speak and/or read English or Spanish.

You may not qualify if…

• Patients with other subtypes of EACs.
• Patients who are considered cognitively impaired. Assessment will be obtained based on their need of a Legally Authorized Representative.

Where it is running

• MD Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.